Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę "New Psychoactive Substances" wg kryterium: Temat


Wyświetlanie 1-5 z 5
Tytuł:
Similarities and differences in changing NPS market brought by new regulatory approaches in selected Eastern and Central European states with mostly focus on Poland and Latvia
Autorzy:
Malczewski, Artur
Zīle-Veisberga, Agnese
Powiązania:
https://bibliotekanauki.pl/articles/1199399.pdf
Data publikacji:
2019-06-30
Wydawca:
Uniwersytet Gdański. Instytut Geografii
Tematy:
New Psychoactive Substances
Law on New Psychoactive Substances
post-communist countries
Opis:
The main objective of the paper is to explain, compare and conclude the effect on the new psychoactive substances (NPS) market brought by new and innovative responses to regulate the NPS (mostly between 2010 and 2014) in Estonia, Latvia, Lithuania, Poland, the Czech Republic, Hungary, and Romania. Countries where NPS problem reached the peak, the traditional response or simply substance scheduling did not work. Since the NPS do not fall under market regulations, also the response to the problem was innovative stepping out of the existing system (for example, temporary prohibition in Poland, Latvia). Moreover, a political and social pressure has been a factor to speed up the development of new regulations, sometime affecting the quality. Seemingly harsh sanctions and immediate reaction are main elements to close the NPS street shops. Meanwhile this approach hasn’t caused a step back for chemical industry or science. Still is open question if national regulations against NPS market are fully enough. NPS market reacts very quickly for changing and only very strong and fast reaction from the institutional level seems to be effectiveness. Although NPS market differs in each country, study shows that harsh sanctions such as criminal liability and immediate reaction significantly decrease the availability of NPS, and thus contribute in decreasing acute health problems and prevalence. It was observed that at the time when stricter measure came into force, hospital emergencies were increased (Poland, Romania and in same extent Latvia).
Źródło:
Journal of Geography, Politics and Society; 2019, 9, 2; 10-19
2084-0497
2451-2249
Pojawia się w:
Journal of Geography, Politics and Society
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities
Autorzy:
Engelgardt, Piotr
Krzyżanowski, Maciej
Piotrowski, Przemysław
Borkowska-Sztachańska, Małgorzata
Wasilewska, Agnieszka
Kowalkowski, Tomasz
Powiązania:
https://bibliotekanauki.pl/articles/2116666.pdf
Data publikacji:
2020-03-13
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
addiction
epidemiology
psychoactive substances
drug users
new psychoactive substances
psychiatric comorbidity
Opis:
ObjectivesThis study analyzed the prevalence of new psychoactive substance (NPS) use in the analyzed group and compared demographic features and psychoactive substance profiles between the 2 subgroups (NPS users, non-NPS users). The secondary measure was used to determine the prevalence of psychiatric comorbidities in study group and to compare demographic features and psychoactive substance profiles between 2 subgroups (the F11–19 only diagnosed group and the F11–19 group with psychiatric comorbidities according to ICD-10).Material and MethodsA 12-month retrospective cross-sectional analysis of medical records compiled for adult psychiatric patients who had been admitted to the Regional Psychiatric Hospital in Olsztyn, Poland, in October 1, 2016 – September 30, 2017 was conducted. After analyzing the available medical records, 157 cases were included and analyzed. Data for the study were collected in a specially designed monitoring card from discharge reports, including data from psychiatric examinations, especially anamnesis. Results: The most commonly declared psychoactive substances were amphetamine (AMF) – 54% and cannabinoids – 46%. The prevalence of NPS use in the study group was 34%. Inpatients taking NPS, as compared with non-NPS users, were younger and more often admitted to hospital through the Emergency Department. It was also found that NPS users more often took AMF or cannabinoids, and less frequently benzodiazepines (BDZ) or opioids. However, the taking of AMF, cannabinoids and BDZ was also age-dependent.ConclusionsThe prevalence of psychiatric comorbidities in the study group was 9%. Inpatients with psychiatric comorbidities were older and took BDZ significantly more often than AMF. In addition, NPS use affects different groups, including a specific group as the analyzed sample, which shows a similar NPS use profile as different groups described in the literature.
Źródło:
International Journal of Occupational Medicine and Environmental Health; 2020, 33, 2; 125-136
1232-1087
1896-494X
Pojawia się w:
International Journal of Occupational Medicine and Environmental Health
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Analytically confirmed presence of psychoactive substances, especially new psychoactive substances in a group of patients hospitalized with mental and behavioural disorders due to the use of psychoactive substances diagnosis
Autorzy:
Engelgardt, Piotr
Krzyżanowski, Maciej
Piotrowski, Przemysław
Borkowska-Sztachańska, Malgorzata
Wasilewska, Agnieszka
Powiązania:
https://bibliotekanauki.pl/articles/2085718.pdf
Data publikacji:
2022-08-01
Wydawca:
Instytut Medycyny Pracy im. prof. dra Jerzego Nofera w Łodzi
Tematy:
THC
epidemiology
addiction
new psychoactive substances
opioids
amphetamine
Opis:
ObjectivesThe study assessed the presence of new psychoactive substances (NPS) in comparison to “classic” drugs in the group of newly admitted patients with mental and behavioral disorders due to the use of psychoactive substances diagnosis (section F11–19 according to ICD-10).Material and MethodsData from anamnesis and the blood and urine samples were collected from 116 patients diagnosed with mental and behavioral disorders due to psychoactive substance use. All of them expressed written informed consent. Analytical confirmation was obtained by highperformance liquid chromatography coupled to tandem mass spectrometry (LC/MS/MS). Liquid-liquid extraction was used for sample preparation.ResultsIn the sample, 108 (93%) of 116 were positive for psychoactive substances (including 96 cases where >1 substance was found), 69% of individuals were tested positive for opioids and 67% for benzodiazepines. Eleven (9%) of 116 patient samples were positive for NPS. We detected 7 different substances. Six of them were synthetic cannabinoids: PB-22, MDMB-CHMICA, MMB-CHMICA, AB-CHMINACA, MMB-FUBINACA, THJ-2201 and one synthetic cathinone 3-CMC.ConclusionsThe prevalence and NPS profile (the predominance of synthetic cannabinoids) are similar in the group of people with addiction to psychoactive substances as in populations of people taking recreational drugs and the overdose patients admitted to the hospital.
Źródło:
International Journal of Occupational Medicine and Environmental Health; 2022, 35, 4; 485-495
1232-1087
1896-494X
Pojawia się w:
International Journal of Occupational Medicine and Environmental Health
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
New psychoactive substances in Poland: An overview of psychodysleptics (lysergamides and tryptamines)
Autorzy:
Słonina, Gabriel
Janczura, Kevin
Powiązania:
https://bibliotekanauki.pl/articles/1163568.pdf
Data publikacji:
2018
Wydawca:
Przedsiębiorstwo Wydawnictw Naukowych Darwin / Scientific Publishing House DARWIN
Tematy:
New psychoactive substances
designer drugs
hallucinogens
lysergamides
psychedelic therapy
psychodysleptics
tryptamines
Opis:
New psychoactive substances (NPS) sometimes referred to as “legal highs” or “designer drugs” are psychotropic materials that mimic the effects of other banned illicit drugs but are not always controlled under drug legislation. NPS are typically marketed as “not for human consumption” and are instead labelled and sold as research chemicals in Poland to avoid legislative controls. One of the main NPS classes are hallucinogens. The present paper aims at providing an overview of two groups of psychedelic drugs – lysergamides and tryptamines, and determining their legislation status in Poland. Psychodysleptics have always been of interest to people who want to experiment with their senses and boundaries. They may show beneficial effects which, from a medical point of view indicate the possibility of using them in therapies. NPS that have been described in this paper: 1-Propionyl-d-lysergic acid diethylamide (1P-LSD), 6-Allyl-6-nor-lysergic acid diethylamide (AL-LAD), 6-Ethyl-6-nor-lysergic acid diethylamide (ETH-LAD), 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET), 5-methoxy-N,N-diallyltryptamine (5-MeO-DALT).
Źródło:
World Scientific News; 2018, 109; 245-262
2392-2192
Pojawia się w:
World Scientific News
Dostawca treści:
Biblioteka Nauki
Artykuł
Tytuł:
Has the COVID-19 pandemic changed substance use patterns, drug market and drug response in Poland?
Autorzy:
Malczewski, Artur
Kidawa, Michał
Dalmata, Małgorzata
Powiązania:
https://bibliotekanauki.pl/articles/2195710.pdf
Data publikacji:
2022-05-27
Wydawca:
Uniwersytet Gdański. Instytut Geografii
Tematy:
Covid-19
drug use patterns
drugs market
new psychoactive substances
drug treatment
Polska
Opis:
The aim of this paper is to examine the impact of COVID-19 on the prevalence of substance use. Moreover, the analysis will focus on the impact of the pandemic on the drug market and drug-related crime in Poland. The tested hypothesis assumes that the COVID-19 pandemic has increased the prevalence of substance use and the related problems, and that the availability of drugs decreased. The data presented and processed for the purposes of this publication come from the monitoring of drugs and drug addiction and from different studies from 2020 to 2022. The analyses presented in the article do not show an increase in the use of psychoactive substances during the pandemic; furthermore, it is possible to indicate a decrease in the consumption of alcoholic beverages in 2020. It seems that the COVID-19 pandemic did not have a large impact on the availability and use of new psychoactive substances (NPS). The analysis of the drug market during the pandemic COVID-19 did not show a fall in the availability of drugs at the national level.
Źródło:
Journal of Geography, Politics and Society; 2022, 12, 1; 42-58
2084-0497
2451-2249
Pojawia się w:
Journal of Geography, Politics and Society
Dostawca treści:
Biblioteka Nauki
Artykuł
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies